Product
mRNA-3927
1 clinical trial
1 indication
Indication
Propionic AcidemiaClinical trial
A Global, Phase 1/2, Open-Label, Dose Optimization Study to Evaluate the Safety, Pharmacodynamics, and Pharmacokinetics of mRNA-3927 in Participants With Propionic AcidemiaStatus: Recruiting, Estimated PCD: 2025-03-05